𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of idiopathic myelofibrosis

✍ Scribed by Y. Matsukawa

Book ID
105990036
Publisher
Springer
Year
2000
Tongue
English
Weight
35 KB
Volume
79
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Idiopathic myelofibrosis: pathogenesis t
Idiopathic myelofibrosis: pathogenesis to treatment
✍ John T Reilly πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 122 KB

## Abstract Idiopathic myelofibrosis (IMF) is the least common of the chronic myeloproliferative disorders and carries the worst prognosis with a median survival of 4 years. It is a clonal haematopoietic stem‐cell disorder and, although the pathogenesis remains unclear, approximately 50% of cases a

Interferon-alpha-2 in the treatment of i
Interferon-alpha-2 in the treatment of idiopathic myelofibrosis
✍ Seewann, H. L. ;Gastl, G. ;Lang, A. ;Abbrederis, K. ;Thaler, J. ;Flener, R. ;Hub πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag βš– 308 KB

We investigated the effect of human recombinant DNA-derived IFN-alpha-2 given in a dose of 1-2 X 10(6) units daily by subcutaneous injection to five patients with advanced idiopathic myelofibrosis (IM). Transfusion dependent anemia and symptomatic splenomegaly were taken as inclusion criteria for th

Idiopathic myelofibrosis terminating in
Idiopathic myelofibrosis terminating in erythroleukemia
✍ Dr. Sonia Garcia; Amparo Miguel; Alicia Miguel; Mariano Linares; Miguel Navarro; πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 166 KB

A 55-year-old woman with a one-year history of idiopathic myelofibrosis progressed to erythroleukemia. This is the first reported occurrence of erythroleukemia progression from idiopathic myelofibrosis. Certain patterns of leukemia transformation from myeloproliferative disorders are favored: Myelob